Pembrolizumab

Gunjur A, et al. Anti-programmed cell death protein 1 (anti-PD1) immunotherapy induced autoimmune polyendocrine syndrome type II (APS-2): A case report and review of the literature. Journal for ImmunoTherapy of Cancer 7: 241, No. 1, 5 Sep 2019. Available from: URL: http://doi.org/10.1186/s40425-019-0713-y - Australia